1 Introduction The expanded clinical spectrum of autoantibody-associated neurological diseases has identified many potentially treatable, and therefore “not to miss,” clinical phenotypes [1-3]. The associated increase in indiscriminate testing has resulted in frequent detection of clinically irrelevant antibodies, representing the commonest precipitant of misdiagnosis and iatrogenic harm in this field [4-6].
Max Herman
- Assignment Editor Fellow, Catchlight.io
Chicago
Documentary photographer | Assignment Editor Fellow @catchlight_io
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Max
Contact Max, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack